Scivita Medical and Boston Scientific Deepen Strategic Collaboration to Advance Global Endoscopy Solutions

Recently, Scivita Medical Technology Co., Ltd. ("Scivita Medical") and Boston Scientific Corporation (NYSE: BSX), a global leading medical technology company, have joined hands again to officially sign a strategic cooperation agreement.

Signing Ceremony Photo
Scivita Medical X Boston Scientific Strategic Cooperation Signing Ceremony

With the iterative updates of endoscopic technology, endoscopes have evolved into interventional tools that integrate diagnosis and treatment. Single-use electronic endoscopes address the issue of cross-infection prevalent in traditional endoscopy, and their penetration rate in the medical endoscope market will continue to increase in the future. According to Frost & Sullivan statistics, the global market size for single-use medical endoscopes was $500 million in 2020 and is expected to grow to $9.2 billion by 2030.

As a minimally invasive diagnosis and treatment enterprise focusing on the research, development, and commercialization of medical endoscopes and related products, "globalization" has always been the strategic goal of Scivita Medical. Through strategic cooperation with local enterprises and multinational corporations such as Boston Scientific, Scivita Medical is continuously advancing towards this goal.

According to the agreement, Scivita Medical and Boston Scientific will further deepen their cooperative relationship in strategic joint research and development as well as global promotion. This includes jointly developing next-generation endoscopic products and conducting commercialization activities worldwide for their single-use endoscopes and imaging devices. This deepened cooperation is expected to help Scivita Medical accelerate its globalization efforts and provide a more comprehensive single-use endoscope solution to medical professionals and patients in China and across the globe.

Dr. Chen Dong (left), Co-founder, General Manager, and Chief Technology Officer of Scivita Medical Technology Co., Ltd.
Mike Jones (right), Global Senior Vice President of Boston Scientific, President of the Endoscopy and Respiratory Interventions Division

Mike Jones, Boston Scientific Global Senior Vice President and President of the Endoscopy and Respiratory Interventions Division, stated: "We are very pleased to further deepen our partnership with Scivita Medical. This is expected to help provide doctors around the world with more choices in endoscopic products. We also look forward to successfully strengthening our partnership through this new agreement."

Dr. Chen Dong, Co-founder, General Manager and Chief Technology Officer of Scivita Medical, stated: "We are very pleased to see the further deepening of our cooperation with Boston Scientific. As a global leading medical technology enterprise, Boston Scientific allows us to combine the core strengths of both companies through this powerful collaboration. Together, we can deliver high-quality, single-use endoscope solutions to doctors and patients in more regions worldwide. Partnering with top international medical technology enterprises like Boston Scientific is an essential part of Scivita Medical's globalization strategy. We will accelerate our innovation and R&D speed, continuously expand innovative business cooperation models, and ensure that more innovative, high-quality, and accessible products benefit patients and healthcare providers globally."

About Scivita Medical
Scivita Medical was founded in October 2016 as a minimally invasive medical company specializing in the research, development, and commercialization of medical endoscopes and related innovative products. The company’s core development strategy is "rooted in China, with a global outlook," and it has established research and development centers in both China and Japan. Leveraging its strong independent R&D capabilities, Scivita Medical has built five core technology platforms and developed a comprehensive portfolio of medical endoscope products and pipeline projects, covering all types of endoscopic surgeries performed across clinical departments in hospitals to meet the diverse needs of doctors and patients worldwide. Guided by its corporate values of "clinical focus," "collaborative innovation," "people-oriented," and "excellence and efficiency," Scivita Medical will continue to advance minimally invasive medical technologies, increase market penetration through outstanding product quality, and become a trusted preferred brand for doctors and patients globally.

For more information, please visit the company website:https://www.scivitamedical.com/#/